PITAVASTATIN 4 MG TABLET
For 30 tablets
Pharmacies pay
$30.87 filed
30 × $1.02909 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$105.07 filed
30 × $3.50225 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.4× estimated
Medicare paid 3.4× what pharmacies pay.
Part D averages every strength and form sold under “Pitavastatin Calcium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$40.50 estimated
$30.87 + $4.63 (15%) + $5.00 fee per fill = $40.50
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
PITAVASTATIN 4 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “pitavastatin” and “pitavastatin calcium”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Inc. and Upsher-Smith Laboratories, LLC.
FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $30.87 for 30 tablets (30 × $1.02909 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Amneal Pharmaceuticals LLC | 1 | $1.02909 per EA filed |
| Aurobindo Pharma Limited | 1 | $1.02909 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $1.02909 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $1.02909 per EA filed |
| NorthStar RxLLC | 1 | $1.02909 per EA filed |
| Teva Pharmaceuticals, Inc. | 1 | $1.02909 per EA filed |
| Upsher-Smith Laboratories, LLC | 1 | $1.02909 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 1 | $1.02909 per EA filed |
All 8 NDCs, with labeler and price
- 00378-5057-77 · Mylan Pharmaceuticals Inc. · $1.02909 per EA · eff. 2026-09-23 filed
- 00480-3633-98 · Teva Pharmaceuticals, Inc. · $1.02909 per EA · eff. 2026-09-23 filed
- 00832-6050-90 · Upsher-Smith Laboratories, LLC · $1.02909 per EA · eff. 2026-09-23 filed
- 31722-0877-90 · Camber Pharmaceuticals, Inc. · $1.02909 per EA · eff. 2026-09-23 filed
- 65162-0031-09 · Amneal Pharmaceuticals LLC · $1.02909 per EA · eff. 2026-09-23 filed
- 65862-0814-90 · Aurobindo Pharma Limited · $1.02909 per EA · eff. 2026-09-23 filed
- 68382-0483-16 · Zydus Pharmaceuticals USA Inc. · $1.02909 per EA · eff. 2026-09-23 filed
- 72603-0480-01 · NorthStar RxLLC · $1.02909 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share an FDA nonproprietary name with PITAVASTATIN 4 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LIVALO 1 MG TABLET | $10.21149 per EA filed | $10.41018 per EA filed |
| LIVALO 2 MG TABLET | $10.20605 per EA filed | $10.41018 per EA filed |
| LIVALO 4 MG TABLET | $10.22248 per EA filed | $10.41018 per EA filed |
| PITAVASTATIN 1 MG TABLET | $0.90443 per EA filed | $3.50225 per EA filed |
| PITAVASTATIN 2 MG TABLET | $0.95425 per EA filed | $3.50225 per EA filed |
| PITAVASTATIN 4 MG TABLET this page | $1.02909 per EA filed | $3.50225 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 8 NDCs’ NADAC prices is $1.02909 per EA filed.
Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 27 have a higher middle NADAC price and 29 a lower one. The one in the middle is PITAVASTATIN 2 MG TABLET, at $0.95425 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $105.07 for 30 tablets, at an average of $3.50225 per EA in 2024 (2024-01-01 to 2024-12-31) for “Pitavastatin Calcium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 162,946 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for PITAVASTATIN 4 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Pitavastatin Calcium / Pitavastatin Calcium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- ATORVASTATIN 10 MG TABLET
- ROSUVASTATIN CALCIUM 10 MG TAB
- SIMVASTATIN 10 MG TABLET
- PRAVASTATIN SODIUM 10 MG TAB
- LOVASTATIN 10 MG TABLET